The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.
Related resource: Generic Drug Registration Application (ANDA) in China
| No. | Drug Name | Dosage Form | Brand Name | Strength | MAH | Note 1 | Note 2 | Batch |
| 90-1 | view | view | / | view | Alimera Sciences, Inc. | Original drug imported to China | Original drug imported to China | The 90th Batch of Reference Listed Drugs |
| 90-2 | view | view | 旁必福 | view | Amgen Europe B.V. | Original drug imported to China | Original drug imported to China | The 90th Batch of Reference Listed Drugs |
| 90-3 | view | view | 旁必福 | view | Amgen Europe B.V. | Original drug imported to China | Original drug imported to China | The 90th Batch of Reference Listed Drugs |
| 90-4 | view | view | 旁必福 | view | Amgen Europe B.V. | Original drug imported to China | Original drug imported to China | The 90th Batch of Reference Listed Drugs |
| 90-5 | view | view | Ryzumvi | view | FAMYGEN LIFE SCIENCES INC | Original drug not imported to China | US Orange Book | The 90th Batch of Reference Listed Drugs |
| 90-6 | view | view | Entresto | view | Novartis Pharmaceuticals Corporation | Original drug not imported to China | US Orange Book | The 90th Batch of Reference Listed Drugs |
| 90-7 | view | view | Entresto | view | Novartis Pharmaceuticals Corporation | Original drug not imported to China | US Orange Book | The 90th Batch of Reference Listed Drugs |
| 90-8 | view | view | Qbrelis | view | AZURITY PHARMACEUTICALS INC | Original drug not imported to China | US Orange Book | The 90th Batch of Reference Listed Drugs |
| 90-9 | view | view | / | view | HIKMA PHARMACEUTICALS USA INC | Original drug not imported to China | US Orange Book | The 90th Batch of Reference Listed Drugs |
| 90-10 | view | view | / | view | BRAINTREE LABORATORIES INC | Original drug not imported to China | US Orange Book | The 90th Batch of Reference Listed Drugs |
